NYSEAMERICAN:IBIO - iBio, Inc.
$0.82
 $0.03
+3.81%
4:00PM EDT
2019-04-18
iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The Company is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The Company's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  IBIO     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 39   199. 07   233. 87  
42 stocks rank:  3. 98 K 1. 43 K 1. 06 K
# analyst opinions:  1. 00   14. 48   14. 09  

quick ratio:  3. 05   5. 29   1. 92  
current ratio:  3. 14   5. 64   2. 40  

target price low:  0. 95   84. 50   115. 74  
target price avg:  0. 95   110. 73   137. 39  
target price high:  0. 95   136. 41   157. 80  
1-yr high:  1. 70   114. 11   138. 85  
last close:  0. 82   87. 56   116. 78  
50-day avg:  0. 86   95. 43   123. 53  
200-day avg:  0. 82   94. 13   121. 20  
1-yr low:  0. 57   72. 67   98. 41  
volume:  30. 19 K 2. 43 M 4. 85 M
50-day avg volume:  79. 66 K 2. 72 M 4. 97 M
200-day avg volume:  117. 40 K 2. 90 M 4. 58 M

1-day return:  3. 80 % -0. 40 % 0. 07 %
this week return:  1. 23 % -5. 72 % -4. 11 %
12-wk return:  -2. 38 % 1. 78 % -0. 04 %
52-wk return:  -50. 15 % 10. 81 % 14. 09 %

enterprise value (EV):  27. 75 M 51. 19 B 117. 96 B
market cap:  15. 32 M 43. 00 B 104. 52 B
EBITDA:  -13. 67 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -2. 03   4. 34   13. 27  
enterprise/revenue (EV/R):  32. 09   68. 16   13. 68  
total revenue:  865. 00 K 10. 61 B 38. 24 B
total debt:  24. 98 M 12. 22 B 16. 66 B
debt/equity:  225. 54   46. 86   89. 46  
net income (common):  -17. 51 M 2. 20 B 4. 21 B

shares outstanding:  19. 04 M 570. 91 M 1. 24 B
shares:  10. 29 M 571. 02 M 1. 23 B
shares short:  417. 43 K 9. 93 M 16. 79 M
shares short prior month:  413. 49 K 9. 96 M 16. 58 M
short ratio:  3. 56   5. 31   3. 30  
short % of float:  4. 36 % 5. 81 % 2. 61 %
total cash/share:  0. 70   11. 13   9. 30  
total cash:  13. 36 M 6. 70 B 7. 10 B
free cash flow:  -7. 73 M 3. 58 B 4. 74 B
operating cash flow:  -12. 32 M 4. 14 B 6. 32 B

book value:  0. 59   12. 76   26. 84  
price/book:  1. 39   3. 08   -1. 74  
gross profits:  444. 00 K 8. 03 B 34. 77 B
operating margins:  -1780. 81 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  100. 00 % 37. 02 % 55. 68 %

1-yr max volatility:  -16. 51 % --- ---
1-yr mean volatility:  -0. 18 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 17   2. 39   4. 08  
P/E:  -0. 70   13. 59   22. 83  
PE/G:  -0. 00   -1. 46   1. 68  
growth:  325. 50 % 126. 81 % 29. 29 %
earnings high:  -0. 00   1. 02   1. 63  
earnings avg:  -0. 00   0. 76   1. 51  
earnings low:  -0. 00   0. 47   1. 39  
revenue high:  -0. 00   2. 68 B 10. 71 B
revenue avg:  -0. 00   2. 59 B 10. 49 B
revenue low:  -0. 00   2. 49 B 10. 25 B
return on assets:  -25. 62 % -2. 80 % 5. 29 %
return on equity:  -182. 65 % -18. 52 % 7. 38 %
revenue growth:  325. 50 % 92. 55 % 19. 15 %
revenue/share:  0. 06   13. 27   55. 24  

beta (1yr vs S&P500):  0. 78   1. 24   0. 93  
sharpe (1yr):  -0. 62   0. 29   0. 60  

held % insiders:  45. 24 % 6. 38 % 3. 38 %
held % institutions:  8. 01 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : IBIO
.        + 0 =             0 :: INITIAL WEIGHT
.   + 42.912 =        42.912 :: spline projection addition
.    x 1.432 =        61.451 :: industry recommendation factor
.    x 1.471 =        90.377 :: EV/R factor
.    x 0.997 =        90.145 :: return on assets factor
.    x 0.982 =        88.499 :: return on equity factor
.    x 2.833 =         250.7 :: revenue growth factor
.    x 2.557 =       641.145 :: current ratio factor
.    x 1.219 =       781.791 :: quick ratio factor
.    x 1.132 =       884.806 :: short ratio factor
.    x 2.014 =      1781.951 :: price-to-book factor
.    x 1.884 =      3357.569 :: debt-to-equity factor
.    x 1.056 =      3545.494 :: 50-day avg > 200-day avg
.    x 2.166 =      7678.252 :: P/E weight
.    x 2.209 =     16960.944 :: PE/G factor
.    x 1.633 =     27693.448 :: beta factor
.    x 0.619 =     17135.881 :: sharpe factor
.    x 1.416 =     24259.103 :: target low factor
.    x 1.135 =     27539.303 :: target mean factor
.    x 1.041 =     28656.422 :: target high factor
.    x 1.312 =      37587.15 :: industry 2-weeks return factor
.    x 0.931 =     34983.922 :: "drift" penalty 1 days ago
.    x 0.998 =     34896.751 :: "drift" penalty 2 days ago
.    x 0.881 =     30758.515 :: "drift" penalty 3 days ago
.    x 0.969 =     29800.888 :: "drift" penalty 4 days ago
.    x 0.984 =     29330.776 :: "drift" penalty 5 days ago
.    x 0.986 =     28922.546 :: overall "drift" factor
.    x 0.999 =     28898.424 :: largest single-day jump factor
.    x 0.061 =      1766.407 :: low price factor
.      x 1.0 =      1766.123 :: factor hist industry gain for week 15
.   cubeRoot =        12.088 :: reduced to standardize
.   - 22.759 =          0.39 :: add/subtract for performance
.                       0.39 :: FINAL WEIGHT for NYSEAMERICAN:IBIO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org